Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Immunology
Factor de Impacto: 1.352 Factor de Impacto de 5 años: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimir: 1040-8401
ISSN En Línea: 2162-6472

Volumes:
Volumen 39, 2019 Volumen 38, 2018 Volumen 37, 2017 Volumen 36, 2016 Volumen 35, 2015 Volumen 34, 2014 Volumen 33, 2013 Volumen 32, 2012 Volumen 31, 2011 Volumen 30, 2010 Volumen 29, 2009 Volumen 28, 2008 Volumen 27, 2007 Volumen 26, 2006 Volumen 25, 2005 Volumen 24, 2004 Volumen 23, 2003 Volumen 22, 2002 Volumen 21, 2001 Volumen 20, 2000 Volumen 19, 1999 Volumen 18, 1998 Volumen 17, 1997 Volumen 16, 1996 Volumen 15, 1995 Volumen 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v31.i3.40
pages 233-263

Function of Histone Deacetylase Inhibitors in Inflammation

Aleksander M. Grabiec
Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Room K0-140, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Paul P. Tak
Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Room K0-140, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Kris A. Reedquist
Division of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

SINOPSIS

Histone deacetylases (HDACs) display multi-faceted roles in coordinating the interaction of intracellular signaling pathways with chromatin remodeling and transcription factor function to finely specify gene alterations and maintenance of gene expression during cellular activation, proliferation, and differentiation. These processes, epigenetic and non-epigenetic, are critical to the development of both the adaptive and innate arms of the mammalian immune system, and the measured initiation and resolution of immune responses. Pharmacological modulators of HDAC activity have demonstrated uniformly potent anti-inflammatory effects in experimental animal models of these diseases, in relevant immune and stromal cell populations from patients, as well as initial successes in the clinic. Recent studies have identified key roles for specific HDACs in regulating immune function, as well as alterations in HDAC expression and function in a number of immune-mediated inflammatory diseases (IMIDs), which may contribute to pathology in these diseases. Here, we review recent advances in our understanding of HDAC function in the immune system, their contribution to IMIDs, and the therapeutic potential of altering HDAC activity in IMIDs.


Articles with similar content:

Modulation of Immune Responses by Histone Deacetylase Inhibitors
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 1-2
Heiko Brennenstuhl, Ulrike Naumann, Sonja Schotterl
The Impact of Extracellular Acidosis on Dendritic Cell Function
Critical Reviews™ in Immunology, Vol.24, 2004, issue 5
Romina Gamberale, Juan Sabatte, Jorge Raul Geffner, Mirta Giordano, Monica Elba Vermeulen, Ana Ceballos, Diego Martinez, Analia Silvina Trevani
Hdac-Mediated Control of Endochondral and Intramembranous Ossification
Critical Reviews™ in Eukaryotic Gene Expression, Vol.21, 2011, issue 2
Meghan E. McGee-Lawrence, Elizabeth W. Bradley, Jennifer J. Westendorf
SLE-Associated Defects Promote Altered T Cell Function
Critical Reviews™ in Immunology, Vol.37, 2017, issue 1
Abel Suárez-Fueyo, Christian M. Hedrich, George C. Tsokos, Denis Comte, Jose C. Crispin
Structure of IL-10 and Its Role in Autoimmune Exocrinopathy
Critical Reviews™ in Immunology, Vol.20, 2000, issue 2
Ichiro Saito